Saunatica
Tirzepatide — Microdosing

WEIGHT LOSS — GLP-1

Tirzepatide — Microdosing

An advanced GLP-1 + GIP dual agonist longevity protocol for metabolic function, insulin sensitivity and nutrient utilization.

1 month plan · total

$229

Compounded medication, not FDA-approved. Prescription requires provider evaluation.

Store in refrigerator between doses.

About

What is Tirzepatide — Microdosing?

Microdosing Tirzepatide is an advanced longevity protocol leveraging dual incretin activity to optimize metabolic function, insulin sensitivity and nutrient utilization. Unlike traditional weight-focused dosing, this approach emphasizes long-term metabolic resilience and healthy aging.

Tirzepatide acts on both GLP-1 and GIP receptors, providing a broader metabolic effect compared to GLP-1 alone. At low doses, it supports glucose regulation, energy balance and hormonal signaling while minimizing excessive appetite suppression.

This dual-pathway activity may offer enhanced benefits in metabolic flexibility, body composition quality and cardiometabolic health, making it a powerful tool for individuals focused on performance and longevity optimization.

Every plan includes

Care, supplies and support

  • Ongoing provider care and support
  • Syringes and alcohol pads kit
  • Platform access and educational content

Dual-pathway metabolism, dialed in

  • Enhanced insulin sensitivity and glucose control
  • Supports metabolic flexibility and nutrient utilization
  • Promotes high-quality body composition
  • May provide greater cardiometabolic benefits vs GLP-1 alone
  • Reduced inflammation and improved metabolic resilience
  • Lower side effect profile at microdoses

Be informed

Possible side effects

Every prescription has trade-offs. Your provider reviews these with you before approving treatment.

  • Mild nausea
  • Occasional bloating
  • Reduced appetite
  • Gallbladder issues (rare)
  • Pancreatitis (rare)
  • Dehydration (rare)

Your questions, answered

Frequently asked questions

Why dual agonist instead of GLP-1 alone?

Tirzepatide activates both GLP-1 and GIP receptors, which broadens metabolic signaling — improving insulin response and nutrient partitioning, and supporting efficient use of carbohydrates and fats for energy.

What should I expect?

Smooth, sustained metabolic support, subtle appetite regulation, improved energy and recovery, and easier adherence to structured nutrition — with precision dosing tailored to your response and ongoing clinician monitoring.

Who should avoid it?

Avoid if you have a history of medullary thyroid carcinoma (MTC) or MEN 2. Use caution when transitioning down from higher doses, maintain hydration and adequate nutrition, and review all medications with your clinician.

How is it shipped?

Discreetly, in unbranded packaging, from an accredited pharmacy. Most orders ship within 24–48 hours of provider approval.

Can I cancel?

Yes. Cancel anytime from your account. Unused months on multi-month plans are refundable per our returns policy.

Also in Weight Loss — GLP-1

Important information

Actual product appearance and labeling of the medication you receive will differ from website images.

This is a compounded medication and is not FDA-approved. Its safety and effectiveness have not been verified by the FDA.

Prescription products require an online consultation with a licensed healthcare provider who will determine whether a prescription is appropriate.

Payment does not guarantee that a prescription will be issued or that medication will be dispensed. Any prescription is based solely on the professional judgment of the licensed provider.

Medications are only issued when clinically appropriate after provider evaluation.